Effect of Acupressure on Fatigue in Hemodialysis Patients

Status Completed

Clinical Trial Summary

OBJECTIVE: To investigate the effect of acupressure on fatigue in patients with end-stage renal disease (ESRD) undergoing hemodialysis (HD) as well as assess sleep quality and psychological status HYPOTHESIS TO BE TESTED: Upon intervention completion, the experimental group will exhibit lower severity of fatigue and depression/anxiety and improved sleep quality compared to the control group. DESIGN AND SUBJECTS: A randomized controlled trial with experimental and control groups. A total of 116 patients with ESRD who screen positive for fatigue severity ≥ 4 (using a single-item indicator of fatigue, which ranges from 0 to 10 points) will be recruited. STUDY INSTRUMENTS: Brief Fatigue Inventory (BFI), Pittsburgh Sleep Quality Index (PSQI), and Hospital Anxiety and Depression Scale (HADS) INTERVENTION: A 4-week acupressure intervention was performed by the principal investigator (PI) for every subject by applying the rate of two rotations per second, three times a week. MAIN OUTCOME MEASURES: Primary: fatigue. Secondary: sleep quality, depression, and anxiety. DATA ANALYSIS: Multiple regression was used to analyze between-group differences in BFI and PSQI, while ordinal logistic regression was used to analyze the subscales of the HADS. EXPECTED RESULTS: The proposed acupressure intervention is useful for alleviating fatigue and related symptoms (sleep quality, depression, and anxiety) experienced by patients with ESRD.

Clinical Trial Description

The prevalence and impact of fatigue and related symptoms in patients with ESRD have been clearly demonstrated in the literature, which also emphasizes the need for evidence-based interventions targeting symptom management in such patients. The main challenge is identifying an intervention that is not only effective in managing hemodialysis-related symptoms, but also feasible, acceptable, and safe for this patient group. The proposed study primarily aims to test the effects of acupressure intervention on fatigue in ESRD patients receiving HD using the robust study design of a randomized controlled trial. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05571007
Study type	Interventional
Source	Chang Gung University
Contact
Status	Completed
Phase	N/A
Start date	July 1, 2019
Completion date	November 30, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04087213` - Study of HemoCare™ Hemodialysis System for Home Nocturnal Dialysis in Patients With ESRD	N/A
Completed	`NCT02207088` - Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney Disease	Phase 3
Not yet recruiting	`NCT03090828` - Economic Evaluation of an Education Platform for Patients With End-stage Renal Disease	N/A
Completed	`NCT02237521` - The Effect of the Incretin Hormones on the Endocrine Pancreatic Function During Hyperglycemia in End-stage Renal Disease	N/A
Withdrawn	`NCT01691196` - Inflammation in Peritoneal Dialysis Patients: Effect of Obesity
Completed	`NCT01394341` - Liraglutide Treatment to Patients With Severe Renal Insufficiency	Phase 4
Active, not recruiting	`NCT00247507` - The Effects of Acetylcysteine on Alleviating Damage of Oxidative Stress in Hemodialysis Patients	Phase 4
Completed	`NCT00307463` - Effects of Strict Volume Control in Hypertensive Hemodialysis Patients on Cardiac Structure and Chronic Inflammation	Phase 4
Recruiting	`NCT00155363` - Effect of Different Hemodialysis Modality on Adiponectin,Vascular Function and Clinical Prognosis	Phase 4
Completed	`NCT00234156` - The Effect of Fructose on Blood Fats in Dialysis Patients and Healthy Volunteers	N/A
Completed	`NCT00586131` - Arterial pH and Total Body Nitrogen Balances in APD	Phase 4
Active, not recruiting	`NCT05027074` - Global Study of MK-2060 (Anti-Factor XI Monoclonal Antibody) in Participants With End Stage Renal Disease Receiving Hemodialysis (FXI Hemodialysis Study) (MK-2060-007)	Phase 2
Recruiting	`NCT04575077` - The Role of Hepcidin as a Biomarker to Predict Successful Renal Transplantation
Enrolling by invitation	`NCT05001009` - Goals of Care Conversations Study	N/A
Completed	`NCT01756508` - Eculizumab for Prevention and Treatment of Kidney Graft Reperfusion Injury	Phase 2
Recruiting	`NCT03862859` - The Danish Warfarin-Dialysis Study - Safety and Efficacy of Warfarin in Patients With Atrial Fibrillation on Dialysis	Phase 4
Terminated	`NCT03661229` - Cardiovascular and Respiratory Assessment Using Biometric Signals in a Non-contact Monitoring Device	N/A
Completed	`NCT03288922` - Protein-bound Toxin Removal Between Limited Blood Flow Super High-flux Online HDF and High-Efficiency Online HDF	N/A
Completed	`NCT02572882` - Gut Microbiome and p-Inulin in Hemodialysis	N/A
Completed	`NCT02360748` - A Plant Based High Protein Diet to Improve Nutritional Outcomes in Peritoneal Dialysis Patients	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.